Heart monitoring device for shock in emergencies
Part of Injuries & trauma clinical trials.
This trial studies a new device called the CRUISE System that is used during emergency care for people with shock. It helps doctors monitor and support your heart and blood flow while you are being treated by emergency medical services or at a UPMC hospital.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older
- You are experiencing signs of shock (a critical condition where your organs aren't getting enough blood flow)
- You are being evaluated, treated, or transported by an emergency medical service (EMS) team that is part of the UPMC system
- You must not have a known irregular heart rhythm or atrial fibrillation
- You must not have an open chest or known right-sided heart failure
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether digital out-of-hospital management improves outcomes for patients who have recovered from early-stage cardiogenic shock. If you have been discharged after treatment for this condition and can use a smartphone, you may be eligible.
This trial is testing a new system called Argos to see if it can measure how much blood your heart pumps more easily than current methods. It is for patients already in the ICU who need a quick change in fluids or blood pressure medicine.
This trial tests a new device that measures heart function closely after heart surgery. It may help doctors give better care if you are in the heart intensive care unit after your operation.
This trial tests if unloading the heart during ECMO support helps patients recover better from cardiogenic shock. It compares different ways to reduce the heart's workload.
This trial tests a new device that measures heart function without needing an invasive catheter. It aims to see if the device works as well as the standard right heart catheterization procedure.
This study tests a special monitoring approach (likely using an implanted device) to help prevent serious complications after you survive cardiogenic shock in the hospital. It may help the care team detect problems earlier so treatments can start sooner.
Hear when a new Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.